I can see the commodity price curve

After agreeing to study those cases, Zhang Yue immediately threw himself into the intense work.

He assembled the most experienced and skilled experts in the research institute to form a special research group.

In the conference room, Zhang Yue looked at everyone with a serious expression and said, "Everyone, these children suffering from autoimmune diseases are in critical condition. We must race against time to develop an effective treatment plan."

Let everyone share their opinions first.

A senior expert adjusted his glasses and spoke first: "Based on the cases collected so far, these children have a variety of autoimmune diseases, and the severity of their conditions varies, which poses a great challenge to treatment."

I believe we can first classify these cases and then study treatment plans for different types of diseases.

Another expert nodded in agreement: "That's right, classification research is a good approach."

Furthermore, we can consult the latest medical literature from both domestic and international sources to see if there are any treatment experiences from similar cases that we can learn from.

Zhang Yue listened attentively to everyone's suggestions, taking notes and thinking as he went, before saying:

"Everyone's ideas are very valuable."

Let's follow this approach: first, classify the cases, then group them to review the data and conduct research.

Throughout this process, everyone should communicate and share new discoveries and ideas.

The research team members immediately sprang into action, working day and night in the laboratory and archives.

Some members carefully analyzed medical records and examination reports, accurately classifying the cases.

Some members sat in front of their computers, searching for useful information in a vast sea of ​​medical literature.

After several days and nights of hard work, the research team finally made some progress.

They found that although these children had different types of autoimmune diseases, they shared some similarities in their pathogenesis, which made it possible to develop a unified treatment framework.

Zhang Yue excitedly called everyone to another meeting. Holding the research report, he said excitedly, "Thank you all for your hard work! After this period of effort, we have made an important discovery."

Next, we will further refine the treatment plan based on this.

We need to take into account each child's specific situation and make personalized adjustments.

Meanwhile, although Mao Mao's parents and other patients' families received Zhang Yue's promise, their worries were not completely eliminated.

They would gather together every day to discuss the changes in the children's conditions, encourage each other, and wait for news from Zhang Yue.

"I wonder how Dr. Zhang and the others are doing with their research. Mao Mao's condition has gotten worse these past few days, and he cries in pain every night."

"It's so worrying," said Mao Mao's mother.

Mao Mao's father patted her on the shoulder and comforted her:

"Don't worry, Dr. Zhang is so capable, and with so many experts working together, there will definitely be a solution."

We must trust them.

Other family members echoed, "Yes, let's wait patiently. Right now, we can only rely on Dr. Zhang."

A few days later, Zhang Yue felt that the treatment plan was basically ready, so he decided to test it on a child whose condition was relatively stable.

He contacted Mao Mao's parents and told them the news.

"Mommy's parents, after this period of research, we have developed a treatment plan."

However, to ensure safety and effectiveness, we want to test it on one child first.

Mao Mao's condition is currently relatively stable. Would you be willing to let him try it first?

Zhang Yue said sincerely over the phone.

Mao Mao's parents were both excited and nervous upon hearing this.

Mao Mao's mother hesitated for a moment and asked, "Dr. Zhang, are there any risks associated with this experiment?"

Zhang Yue patiently explained, "Any treatment carries certain risks, but we have done thorough research and preparation, and will do our best to ensure the child's safety."

Moreover, this is currently the only possible way to cure the children.

After thinking for a moment, Mao Mao's father said firmly, "Dr. Zhang, we believe in you."

Let Mao Mao give it a try. Even if there are risks, we're willing to take the gamble.

So, Mao Mao was taken to the research institute and began experimental treatment.

Zhang Yue and the experts closely monitored Mao Mao's condition and adjusted the treatment plan promptly based on his reactions.

In the first few days, Mao Mao did not show any significant improvement. He still got red rashes on his body from time to time, which made him very uncomfortable.

Mao Mao's parents saw this and were anxious, but they didn't complain. Instead, they silently supported Zhang Yue's work.

"Dr. Zhang, no matter the outcome, we are grateful for everything you have done for Mao Mao," Mao Mao's father said sincerely.

Zhang Yue said gratefully, "Thank you for your understanding and support. We will not give up and will definitely find a way to cure Mao Mao."

Just when everyone was feeling somewhat discouraged, a miracle happened.

On the tenth day of treatment, the red rash on Mao Mao's body decreased significantly, and the itching was also greatly reduced.

He started to regain his spirits and was able to talk and laugh with his parents in the ward.

Zhang Yue and the experts were thrilled. They immediately summarized and analyzed the treatment plan for this stage and concluded that the plan was feasible.

Therefore, they decided to extend this treatment plan to other children.

After the news spread, the patients' families cheered with joy, as if they could see the dawn of their children's recovery.

Zhang Yue led the experts to develop personalized treatment plans for each child and personally supervised the treatment process.

As time went on, the children's conditions improved significantly.

The rash gradually subsided, and his mental state improved.

The patients' families were deeply grateful to Zhang Yue, and they presented him with banners and letters of thanks to express their respect and gratitude to Zhang Yue and his team.

"Dr. Zhang, you are like a second parent to our child! If it weren't for you, our child would have suffered so much more."

A patient's family member held Zhang Yue's hand tightly and said excitedly.

Zhang Yue smiled and said, "This is what I should do. I'm also very happy to see the children recover."

However, medical research is a never-ending process, and we must continue our efforts to bring hope to more patients.

Under Zhang Yue's leadership, the institute's special research team did not stop working because of the children's recovery.

They continue to delve into the pathogenesis and treatment of autoimmune diseases, hoping to find more effective and safer treatment methods.

At the same time, Zhang Yue also realized that in order to raise public awareness and attention to autoimmune diseases, more patients can receive timely treatment.

Therefore, he organized a series of public awareness campaigns, inviting experts to explain knowledge about autoimmune diseases and share treatment experiences with the public.

These public welfare activities have received widespread attention and support from all sectors of society, and more and more people are beginning to understand autoimmune diseases and pay attention to the health of patients.

Zhang Yue and his team's efforts have not only brought hope to children suffering from autoimmune diseases, but have also made significant contributions to the research and treatment of autoimmune diseases in the entire medical community.

After successfully overcoming the challenge of children's autoimmune diseases, Zhang Yue was not satisfied with his existing achievements.

He knew that the ocean of medicine was vast and boundless, and countless illnesses were waiting to be cured.

Therefore, he turned his attention to the more complex and challenging field of genetic defects and decided to use the newly acquired supercomputer at the institute to accelerate the research process in this area.

"Everyone, the treatment of genetic defects is our main focus going forward."

Although the challenges are immense, I believe that with our intelligence and the powerful computing capabilities of supercomputers, we will definitely find a breakthrough.

Zhang Yue stated firmly at the research group meeting.

The research team members were both excited and somewhat apprehensive upon hearing this.

They knew it would be a tough battle, but Zhang Yue's determination and past successes filled them with confidence.

After countless days and nights of hard work, the supercomputer finally captured a crucial clue in the analysis of massive amounts of data.

Zhang Yue excitedly gathered everyone: "I have discovered a gene mutation pattern that is closely related to the first immunodeficiency disease. Perhaps we can start from here and develop new treatment methods."

The team members immediately began in-depth research on this clue.

However, the process was not without its challenges.

They encountered enormous difficulties during the drug screening phase.

Many drugs that seemed promising performed poorly in initial trials, and some even showed unexpected side effects.

"Dr. Zhang, this can't go on. We've screened so many drugs, but none of them have the desired effect. Are we going in the wrong direction?" a young researcher said anxiously.

Zhang Yue frowned, pondered for a moment, and then said, "The direction should be correct, and the analysis of gene mutation patterns should not be wrong."

Perhaps our screening method is not precise enough, or we have overlooked some key factors.

Let's all review the entire research process carefully again, and see if there's anything we've overlooked.

Encouraged by Zhang Yue, the team members re-examined their research approach and conducted a detailed review of each step.

Finally, they discovered that there had been a discrepancy in their previous assessment of the drug's target.

After adjustments, they re-screened the drugs, and this time, a new drug showed amazing efficacy in the trials.

"Success! This drug has a significant therapeutic effect on the first type of immunodeficiency disease!" A cheer erupted in the laboratory.

After further clinical trials and optimization, this treatment method finally matured and was successfully applied to a large number of patients.

Many patients who were originally suffering terribly from illness gradually recovered after receiving treatment and returned to a normal life.

However, Zhang Yue did not stop.

Soon, they faced a second challenge—an even rarer immunodeficiency disease.

The pathogenesis of this disease is extremely complex, involving the interaction of multiple genes, making it extremely difficult to treat.

"Dr. Zhang, this disease is too complicated. Can we really overcome it?" an expert asked worriedly.

Zhang Yue said with a firm gaze, "Medical progress is achieved by constantly challenging the impossible."

We already have the powerful tool of supercomputers, and the experience we've accumulated. As long as we work together, we will definitely find a solution.

During the research process, they encountered numerous difficulties once again.

Interpreting genetic data is extremely complex, and the interactions between different genes are intricate, like a giant maze.

Moreover, due to the small number of patients with this disease, the available data for research is also very limited.

"Dr. Zhang, there's too little data. It's difficult for us to find any patterns," a researcher said helplessly.

After a moment of contemplation, Zhang Yue said, "We can try to collaborate with research institutions in other countries and share data."

At the same time, simulation experiments were conducted using supercomputers to expand the data sample as much as possible.

With Zhang Yue's active promotion, they established cooperative relationships with several top international research institutions to conduct joint research.

After countless simulation experiments and data analysis, they finally identified the key pathogenic gene for this immunodeficiency disease and developed a targeted treatment method.

The entire research team was thrilled when the first batch of patients showed significant improvement after receiving treatment.

With the promotion of treatment, more and more patients have been freed from the torment of illness and have regained hope for life.

After the news spread, the patients who had been cured by Zhang Yue and his team flocked to the research institute, their eyes filled with gratitude and respect.

"Dr. Zhang, you are our savior! If it weren't for you, we don't know how much longer we would have struggled with this illness."

A patient gripped Zhang Yue's hand tightly, his voice trembling as he spoke.

Another patient added, "Dr. Zhang, we want to erect a monument and write a biography for you so that future generations will always remember your kindness."

Zhang Yue quickly waved his hand and said with a smile, "I appreciate everyone's kindness, but I cannot accept having a monument erected and a biography written on it."

As a doctor, saving lives is my duty.

Seeing everyone recover is the greatest reward for me.

An elderly patient with gray hair became emotional, his eyes reddening, and he shouted:

"Dr. Zhang, please don't refuse!"
You've done so much for us, what's a monument compared to that? This is our collective sentiment, you must accept it!

A young mother nearby chimed in, holding her newly recovered child in her arms:

"Dr. Zhang, look at this child. He used to be so thin and weak from being sick, but now he's so healthy and lively."

"If it weren't for you, we don't know what would have become of our family. This monument must be erected!"

Others also gathered around, offering their own words of advice.

Looking at everyone's sincere and eager eyes, Zhang Yue was deeply moved, and his eyes welled up with tears.

He took a deep breath and said:
"Since everyone insists, I'll shamelessly accept this token of my appreciation."

But this is absolutely not for my personal sake, but to inspire more medical workers and to ensure that more patients can receive treatment.

Soon, a monument inscribed with "A doctor's heart is benevolent, saving lives and healing the wounded - a tribute to Dr. Zhang Yue and his team" was erected in the small square outside the research institute.

Every day, recovered patients and their families come to lay flowers, and this place has gradually become a gathering place for everyone's gratitude and hope. Zhang Yue stood in front of the monument, gazing at the words on it for a long time, and silently vowed in his heart: "I must continue to work hard and live up to everyone's expectations."

Upon returning to the research institute, he immersed himself in the vast ocean of data from supercomputers, leading his team to conduct more in-depth research on the medical industry.

As the days went by, the research hit a bottleneck.

Despite the continuous operation of supercomputers analyzing massive amounts of genetic data, no groundbreaking discoveries have been made.

The team members were somewhat frustrated, and one of the young researchers couldn't help but complain:

"Dr. Zhang, this research at the genetic level is too complex. It feels like we're groping in the dark, and we don't know when we'll find a way out."

Zhang Yue patted him on the shoulder and encouraged him, "Don't be discouraged. Medical research is never smooth sailing."

We already have the powerful tool of supercomputers, so success is certainly not far away.

Let's all think about this carefully. Is there some step we've overlooked?

Encouraged by Zhang Yue, the team members rallied and repeatedly reviewed and verified the previous data and experiments.

Finally, during a late-night experiment, a researcher excitedly shouted:
"Dr. Zhang, I've discovered a crucial clue!"
Supercomputer simulations show that certain gene sequences can activate the body's self-repair mechanisms by injecting corresponding vaccines, thereby achieving the goal of fundamentally treating various diseases at the gene level!

Upon hearing this news, Zhang Yue instantly stood up from his chair, his eyes gleaming with excitement:
"Really? Quick, show me the detailed data!"

He studied the data carefully, a satisfied smile spreading across his face:
"This could very well be a major breakthrough! We'll conduct further experiments to verify it immediately."

In the days that followed, the team members worked day and night in the laboratory, developing and testing various possible vaccines.

However, the process did not go smoothly.

Many vaccines have either been ineffective or caused serious side effects in initial trials.

"Dr. Zhang, this can't go on. We've tried so many vaccines, but none of them have achieved the desired results."

One expert expressed concern.

Zhang Yue frowned, pondered for a moment, and then said, "Everyone, don't worry. We've found a key clue, and we're not far from success."

The vaccine formulation or injection method may need adjustment. We will reanalyze the data and optimize the treatment plan.

Finally, after countless trials and improvements, a new type of vaccine has shown amazing efficacy in trials.

"Success! This vaccine has significant therapeutic effects on a variety of diseases, with minimal side effects!"

A cheer erupted in the laboratory.

Zhang Yue was so moved that tears welled up in his eyes. He tightly grasped the hands of his team members and said:
"Thank you all for your hard work! This is the result of our joint efforts."

Next, we need to expedite the clinical application of this vaccine so that more patients can benefit.

Zhang Yue stood in the research institute's conference room, his gaze fixed firmly on the crowd below, his voice steady and powerful:
"Ladies and gentlemen, after years of unremitting efforts, we have developed a new type of vaccine that is expected to overcome one of the most difficult diseases to conquer in humankind—AIDS."

Next, we will conduct comprehensive clinical trials to give more patients hope.

However, as soon as he finished speaking, the conference room erupted in chaos.

A senior expert frowned and said with a look of doubt, "Dr. Zhang, this is no joke."

"Easy to get rid of AIDS has been a persistent problem for so many years. Can your vaccine really have such miraculous effects? The risk is too great; if it fails, the consequences would be unimaginable."

Another young researcher chimed in, "Yes, Dr. Zhang, people's understanding of E.S. is still very limited."

Furthermore, the safety of vaccines has not been fully verified; wouldn't it be too risky to promote them prematurely?

Zhang Yue smiled slightly and patiently explained, "I understand everyone's concerns."

However, our research is based on a large amount of data and experiments, and supercomputers have conducted countless simulations and analyses, which show that this vaccine is highly feasible.

Furthermore, we will not immediately roll it out on a large scale; we will first conduct small-scale clinical trials to ensure safety and efficacy before gradually expanding its scope.

Despite Zhang Yue's clear explanation, many people remain skeptical.

However, thanks to Zhang Yue's persistence and the team's joint efforts, the clinical trial was officially launched.

They contacted several hospitals to find eligible patients.

Soon, a young patient named Quinoa came into their view.

Quinoa is only 25 years old, but she is emaciated by AIDS, and her eyes are filled with despair and helplessness.

When Zhang Yue and his team arrived at his hospital room, Li Mai's parents were by his bedside, their faces streaked with tears.

Zhang Yue walked to Limai's bedside and said softly, "Limai, I am Dr. Zhang Yue."

We've developed a new vaccine that might treat your illness. Would you like to participate in our clinical trial?

Upon hearing this, a glimmer of hope flashed in the eyes of Quinoa's parents, but it was quickly replaced by worry.

Quinoa's father hesitated for a moment and asked, "Dr. Zhang, is this vaccine really safe? We don't want our child to suffer any more."

Zhang Yue said sincerely, "I understand how you feel."

We have achieved good results in animal experiments, but there are still certain risks in human trials.

However, we will closely monitor Quinoa's condition throughout the process and do our utmost to ensure his safety.

Lying in bed, Quinoa said weakly, "Mom and Dad, I want to try."

I don't want to lie in bed waiting to die like this. Even if there are risks, I'm willing to take the gamble.

Seeing the determination in their son's eyes, Quinoa's parents finally nodded: "Dr. Zhang, thank you for your help."

Thus, quinoa became the first patient in the clinical trial.

Zhang Yue and his team carefully devised a treatment plan for him and strictly followed the procedures to administer the vaccine.

In the days that followed, everyone anxiously monitored the changes in quinoa's condition.

However, things did not go so smoothly.

On the third day after receiving the vaccine, Quinoa suddenly experienced adverse reactions such as fever and headache.

Quinoa's parents panicked and rushed to Zhang Yue: "Dr. Zhang, what happened? Is something wrong with our child?"

Zhang Yue was also a little nervous, but he calmly reassured her, "Don't worry, this is a normal reaction that may occur with the vaccine."

We will examine quinoa immediately and adjust the treatment plan accordingly.

After a thorough examination, Zhang Yue discovered that quinoa's body had developed a certain degree of rejection reaction to the vaccine.

He immediately convened a meeting with his team members to discuss countermeasures.

"As you can see, quinoa has caused a rejection reaction, which means that the adaptability of our vaccine in the human body still needs further adjustment."

"We need to reanalyze the data and find out where the problem lies," Zhang Yue said seriously.

The team members shared their opinions, and after a heated discussion, they finally found the possible cause and made minor adjustments to the vaccine formula.

Zhang Yue visited Li Mai's hospital room again and said to Li Mai's parents:
"We have identified the problem and adjusted the vaccine accordingly."

"We will continue to treat quinoa, don't worry, we won't give up."

Quinoa's parents said gratefully, "Dr. Zhang, thank you."

Regardless of the outcome, we are grateful for everything you have done for the child.

In the days that followed, Zhang Yue and his team stayed by Li Mai's side day and night, closely monitoring the changes in his condition.

After a period of careful treatment, the adverse reactions to quinoa gradually disappeared, and her physical condition began to improve slowly.

Another month passed, and when the test results came out, everyone was stunned.

The viral load in quinoa decreased significantly, and the immune system gradually recovered.

Zhang Yue excitedly ran to Li Mai's ward and said, "Li Mai, the viral load in your body has decreased, and your immune system is recovering. This is a very good sign!"

Quinoa and his parents were moved to tears upon hearing this.

Quinoa held Zhang Yue's hand tightly and said, "Dr. Zhang, thank you. You gave me a second life."

The success story of quinoa has given more people hope.

More and more patients with sepsis are voluntarily signing up for clinical trials, making Zhang Yue and his team members even busier.

They continuously optimize vaccine formulations and adjust treatment plans to provide the most precise treatment for each patient.

As time went on, more and more patients saw their conditions improve.

The news of the clinical trial's great success quickly spread throughout the medical community.

Those who had previously been skeptical of Zhang Yue now had to give him a thumbs up.

Following the great success of the clinical trials of the eissetial disease vaccine, Zhang Yue immediately threw himself into new research.

After a period of hard work, he and his team successfully launched the second vaccine—a vaccine that can promote the healthy development of infants and young children.

Zhang Yue held a press conference with great confidence, where he detailed the vaccine's efficacy and safety:
"Dear friends from the media and people from all walks of life who are concerned about our research, the vaccine we have developed this time is specifically designed for the healthy development of infants and young children."

It can enhance infants' and young children's immunity, promote the overall development of their brain and body, and make children healthier and smarter as they grow up.

Moreover, we conducted countless experiments and simulations during the research and development process, ensuring absolute safety.

After the press conference, Zhang Yue thought that with the previous success of the E. coli vaccine, people would be eager to have their children vaccinated with this new vaccine.

However, reality dealt him a heavy blow.

When he organized a team to promote the program in the community, he found that very few people were willing to cooperate.

A young mother, holding her adorable child, said with a wary expression:

"Dr. Zhang, my child is perfectly healthy, eats and sleeps well, why do we need to give him this vaccine?"

What if something serious happens during the fight?

An elderly woman with gray hair nearby chimed in, "That's right, the child is perfectly fine, we can't let him get into trouble."

This vaccine sounds good, but who knows if it has any side effects? We can't risk our child's health.

Zhang Yue patiently explained, "Please don't rush to refuse."

While this vaccine cannot cure diseases, it can make children healthier and reduce their risk of getting sick in the future.

Furthermore, in our previous experiments, the infants who received the vaccine were significantly healthier and more active during their development compared to those who did not.

At this moment, a young father frowned and said:
"Dr. Zhang, we understand what you're saying, but our child is the apple of our eye, and we really don't dare to try anything lightly."

"If there are any potential problems with this vaccine, we might not be able to see them now, but it will be too late if something goes wrong later."

Seeing the determined looks in everyone's eyes, Zhang Yue felt a little disappointed, but he still continued to persuade them:

"I understand everyone's concerns. But medical research is a continuous process of progress, and we cannot refuse to progress just because we are afraid of risks."

This vaccine has undergone rigorous testing and experimentation, and its safety is guaranteed.

However, no matter what Zhang Yue said, everyone remained unmoved.

Seeing everyone's resolute attitude, Zhang Yue fell into deep thought.

He knew that people were reluctant to vaccinate their children because of fear of unknown risks, and that since the children were healthy, there was no need to take the risk.

Back at the research institute, the team members gathered around, looking dejected, and asked:
"Dr. Zhang, what should we do? No one is willing to cooperate, and our research can't continue."

Zhang Yue took a deep breath and said slowly, "Everyone, please don't rush."

After careful consideration, I realized that we really cannot force people to accept this vaccine.

Everyone has the right to decide their own child's health, and we should respect everyone's choices.

One researcher said anxiously, "But Dr. Zhang, our vaccine is clearly good for children. It would be such a waste to give it up like this."

Zhang Yue shook his head and said, "No, this is not giving up."

We can continue to refine the vaccine and improve its safety and effectiveness in subsequent studies.

At the same time, we can also strengthen publicity and education to help people better understand the role and benefits of this vaccine.

But we're not forcing everyone to accept it now.

In the days that followed, Zhang Yue did not give up despite the setbacks in promotion.

He led his team to continue optimizing and improving the vaccine, while also organizing a series of science popularization activities.

They invited medical experts and parenting gurus to explain the knowledge of infant and toddler health development, as well as the role and safety of this vaccine, through a combination of online and offline methods.

During a science lecture, a parent stood up and asked a question:

"Dr. Zhang, I'm still a little worried about the side effects of the vaccine. Can you guarantee it's absolutely safe?"

Zhang Yue smiled and replied, "No medical procedure can guarantee absolute safety, but we will do our best to reduce the risks."

Our vaccine has undergone multiple rounds of experiments and tests, and we will continue to monitor its safety and efficacy in subsequent studies.

If you have any questions, please feel free to contact us. (End of Chapter)